SCHEMBL12705231

SCHEMBL12705231

CC(=O)NCCCCCNC(=O)c1ccc2ncccc2c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 1/20 0.61
HTR1A P08908 1/20 0.60
ADRA2A P08913 1/20 0.60
ADRA2B P18089 1/20 0.60
ADRA2C P18825 1/20 0.60
ADRA1D P25100 1/20 0.60
HTR2A P28223 1/20 0.60
ADRA1A P35348 1/20 0.60
HRH1 P35367 1/20 0.60
ADRA1B P35368 1/20 0.60
DRD3 P35462 1/20 0.60
KCNH2 Q12809 1/20 0.60
ALOX15 P16050 1/20 0.54
HTT P42858 1/20 0.54
HDAC1 Q13547 10/20 0.53
HDAC6 Q9UBN7 8/20 0.53
HDAC3 O15379 8/20 0.52
HDAC2 Q92769 8/20 0.51
HDAC4 P56524 7/20 0.51
HDAC8 Q9BY41 7/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12422565 0.96 PLK1 (0.63) PLK1HTR1AADRA2AADRA2BADRA2C
SCHEMBL3980469 0.90 PLK1 (0.61) PLK1HTR1AADRA2AADRA2BADRA2C
SCHEMBL3981507 0.90 PLK1 (0.61) PLK1HTR1AADRA2AADRA2BADRA2C
SCHEMBL3981757 0.90 PLK1 (0.61) PLK1HTR1AADRA2AADRA2BADRA2C
SCHEMBL3976758 0.90 PLK1 (0.61) PLK1HTR1AADRA2AADRA2BADRA2C
SCHEMBL13382890 0.89 PLK1 (0.63) PLK1HTR1AADRA2AADRA2BADRA2C
SCHEMBL24219845 0.87 PLK1 (0.64) PLK1HTR1AADRA2AADRA2BADRA2C
SCHEMBL1041880 0.87 HTR1A (0.62) PLK1HTR1AADRA2AADRA2BADRA2C
SCHEMBL1041626 0.87 HTR1A (0.62) PLK1HTR1AADRA2AADRA2BADRA2C
SCHEMBL3979860 0.84 HTR1A (0.62) PLK1HTR1AADRA2AADRA2BADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7919581-B2 Bi-dentate compounds as kinase inhibitors BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2011-04-05 US disclosed
US-7919581-B2 Bi-dentate compounds as kinase inhibitors BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2011-04-05 US disclosed
US-20090054348-A1 BI-DENTATE COMPOUNDS AS KINASE INHIBITORS NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2009-02-26 US disclosed
US-20090054348-A1 BI-DENTATE COMPOUNDS AS KINASE INHIBITORS NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2009-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054348-A1 BI-DENTATE COMPOUNDS AS KINASE INHIBITORS MAP2K2, MAP2K1, MAP2K7 PLK1 182/4885HTR1A 2063/4885ADRA2A 1777/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.